Calixto Machado | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Dr. Calixto Machado | Clinical Neuroscience | Best Researcher Award

Prof. Dr. Calixto Machado | Institute of Neurology and Neurosurgery | Cuba

Calixto Machado is a Full Professor and Senior Researcher in Neurology and Clinical Neurophysiology at the Institute of Neurology and Neurosurgery in Havana, Cuba, and a Corresponding Fellow of the American Academy of Neurology. He completed his medical degree, followed by specialist training in neurology and clinical neurophysiology, and then earned his PhD. Over four decades he has led pioneering research on disorders of consciousness, brain death, stroke, autism, autonomic nervous system disorders and the neurological sequelae of SARS-CoV-2. He has published nearly 700 peer-reviewed journal articles, book chapters and authored seven books; his work is recognised internationally through numerous symposia and awards. His Google Scholar profile lists an h-index of 37, and over 24 000 citations across his published documents.

Profile: Google Scholar

Featured Publications:

Machado, C. (2025, September 9). Jahi McMath case: A comprehensive and updated narrative. World Journal of Critical Care Medicine, 14(3), 107513.

Machado, C. (2022). The Jahi McMath case: First detailed study of her brain. Neurology India, 70(5), 22–35.

Giacino, J. T., Ashwal, S., Childs, N., Cranford, R., Jennett, B., Katz, D. I., Kelly, J. P., & others. (2002). The minimally conscious state: Definition and diagnostic criteria. Neurology, 58(3), 349–353.

Sloan, M. A., Alexandrov, A. V., Tegeler, C. H., Spencer, M. P., Caplan, L. R., & others. (2004). Assessment: Transcranial Doppler ultrasonography report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology, 62(9), 1468–1481.

Machado, C. (2002). Brain death worldwide: Accepted fact but no global consensus in diagnostic criteria. Neurology.

Machado, C. (2007). Cerebral response to patient’s own name in the vegetative and minimally conscious states. Neurology, 69(7), 708.

Machado, C., Korein, J., Ferrer, Y., Portela, L., & others. (2007). The concept of brain death did not evolve to benefit organ transplants. Journal of Medical Ethics, 33, 197–200.

Machado, C. (2007). The concept of brain death did not evolve to benefit organ transplants. In C. Machado (Ed.), Brain death: A reappraisal (pp. 1–20). Springer.

Machado, C. (2007). Brain death: A reappraisal. Springer Science & Business Media.

Machado, C. (2007). The first organ transplant from a brain-dead donor. In C. Machado (Ed.), Brain death: A reappraisal (pp. 1–20). Springer.

Machado, C. (2010). Diagnosis of brain death. Neurology International, 2(1), e2.

Graf, W. D., Miller, G., Epstein, L. G., & Rapin, I. (2017). The autism “epidemic”: Ethical, legal, and social issues in a developmental spectrum disorder. Neurology, 88(14), 1371–1380.

Machado, C., Korein, J., Aubert, E., Bosch, J., Alvarez, M. A., Rodríguez, R., & others. (2007). Recognizing a mother’s voice in the persistent vegetative state. Clinical EEG and Neuroscience, 38(3), 124–126.

Lewis, A., Bernat, J. L., Blosser, S., Bonnie, R. J., Epstein, L. G., Hutchins, J., & others. (2018). An interdisciplinary response to contemporary concerns about brain death determination. Neurology, 90(9), 423–426.*

Kathrin Eichinger | Clinical Neuroscience | Outstanding Contribution Award

Published on by Neuroscientists

Dr. Kathrin Eichinger | Clinical Neuroscience | Outstanding Contribution Award 

Dr. Kathrin Eichinger | Medizinische Universitat Wien | Austria

Dr. Med. Kathrin Eichinger is an Austrian physician specializing in Pediatrics and Pediatric Neurology, currently serving as a Consultant in Child and Adolescent Medicine with subspecialty training in Neuropediatrics at the Medical University of Vienna. Her clinical and academic focus lies in neuroimmunology, with ongoing doctoral research in neuroscience examining acute necrotizing encephalitis. Dr. Eichinger’s experience spans several leading medical institutions, including Sankt Anna Children’s Hospital and the Hospital of the Brothers of Mercy in Eisenstadt, complemented by an observership in Neurointensive Care and Neuroimmunology at the Children’s Hospital of Philadelphia. She has also contributed to clinical research through her involvement in the eSMART randomized controlled trial on electronic symptom management at the Medical University of Vienna. Her expertise is further supported by certification in pediatric EEG and active participation in numerous neuropediatric congresses and workshops across Europe. Multilingual in German, English, and Spanish, Dr. Eichinger combines her clinical acumen with strong research engagement, reflected in her growing academic footprint with an h-index of 3, five peer-reviewed documents, and approximately 45 citations. Her professional pursuits integrate advanced clinical training, translational neuroscience, and a dedication to improving pediatric neurocare.

Profile: Orcid

Featured Publications

  • Eichinger, K., Breu, M., Renken, M., Siegert, S., Hilz, E., Glatter, S., Csaicsich, D., Boehm, M., Lechner, C., Kornek, B., et al. (2025). Complications of therapeutic plasma exchange in pediatric neuroimmune disorders. Children, 12(11), 1457.

  • Grasl, S., Janik, S., Dressler, A., Diehm, R., Gröppel, G., Eichinger, K., Grasl, M. C., Gstoettner, W., Feucht, M., Vyskocil, E., et al. (2021). Management and outcome of vagus nerve stimulator implantation: Experience of an otolaryngeal/neuropediatric cooperation. European Archives of Oto-Rhino-Laryngology, 278(10), 3729–3738.

Ricardo Osorio | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Ricardo Osorio | Clinical Neuroscience | Best Researcher Award

Dr. Ricardo S. Osorio is a tenured Associate Professor of Psychiatry and Radiology at NYU Grossman School of Medicine, where he directs the Healthy Brain Aging and Sleep Center and serves as Director of the Biomarker Core within the NYU Alzheimer’s Disease Research Center. A physician-scientist, Dr. Osorio investigates the interplay of sleep, vascular, and inflammatory mechanisms in Alzheimer’s disease, integrating multimodal biomarkers, neuroimaging, and detailed clinical phenotyping. He has led several landmark studies, including trials on sleep apnea, amyloid and tau accumulation, brain energetics, and locus coeruleus dysfunction, exploring how sleep and metabolic factors influence cognitive decline and neurodegeneration. His work has significantly advanced translational biomarker development, assay harmonization, and inclusive recruitment in aging research. Dr. Osorio has published over 130 peer-reviewed articles in top journals such as JAMA Neurology, Annals of Neurology, Sleep, Alzheimer’s & Dementia, Lancet, and Brain, contributing to more than 8,369 citing documents, with a total citation count of 9,893 and an h-index of 44. He serves on multiple editorial boards, including Sleep Medicine Reports, and has provided expert peer review for leading journals worldwide. His collaborative network spans the NYU Alzheimer’s Disease Research Center, Mount Sinai, the ENIGMA-Sleep Consortium, and numerous national and international aging and sleep research initiatives, mentoring the next generation of clinician-scientists while shaping the field of sleep and neurodegeneration.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

  1. Author(s). (Year). Disordered sleep and painful diabetic neuropathy (PDN): A review of the literature on pathophysiology, pharmacologic and nonpharmacologic treatment options, and future directions. Journal Name, Volume(Issue), pages.

  2. Author(s). (2025). EEG slow oscillations and overnight spatial navigational memory performance in CPAP-treated obstructive sleep apnea. Sleep, Volume(Issue), pages.

  3. Author(s). (2025). High-frequency oscillations >250 Hz in people with Down syndrome and associated Alzheimer’s disease dementia. Alzheimer’s & Dementia, Volume(Issue), pages.

  4. Author(s). (2025). Impact of Alzheimer’s disease on sleep in adults with Down syndrome. Alzheimer’s & Dementia, Volume(Issue), pages.

  5. Author(s). (2025). Sleep-wake variation in body temperature regulates tau secretion and correlates with CSF and plasma tau. Journal of Clinical Investigation, Volume(Issue), pages.

  6. Author(s). (2025). The stability of slow-wave sleep and EEG oscillations across two consecutive nights of laboratory polysomnography in cognitively normal older adults. Journal of Sleep Research, Volume(Issue), pages.

  7. Author(s). (2025). Two-year longitudinal outcomes of subjective cognitive decline in Hispanics compared to non-Hispanic Whites. Journal of Geriatric Psychiatry and Neurology, Volume(Issue), pages.

  8. Author(s). (Year). Enhancing sleep, wakefulness, and cognition with transcranial photobiomodulation: A systematic review. Journal Name, Volume(Issue), pages.

  9. Author(s). (2024). The relationship between anxiety and levels of Alzheimer’s disease plasma biomarkers. Journal of Alzheimer’s Disease, Volume(Issue), pages.

  10. Author(s). (2024). The neutrophil to lymphocyte ratio associates with markers of Alzheimer’s disease pathology in cognitively unimpaired elderly people. Immunity and Ageing, Volume(Issue), pages.

Noreen Kamal | Translational Neuroscience | Best Researcher Award

Published on by Neuroscientists

Assoc. Prof. Dr. Noreen Kamal | Translational Neuroscience | Best Researcher Award

Assoc. Prof. Dr. Noreen Kamal | Dalhousie University | Canada

Dr. Noreen Kamal, Ph.D., P.Eng., is an Associate Professor of Industrial Engineering at Dalhousie University, Canada, with cross-appointments in the Departments of Community Health and Epidemiology and Medicine (Neurology). Her research lies at the intersection of health systems engineering and clinical neuroscience, focusing on the optimization of stroke care systems, development of data-driven quality improvement frameworks, and evaluation of biomedical devices for stroke rehabilitation. Dr. Kamal has played a pivotal role in advancing integrated approaches to enhance the efficiency, safety, and accessibility of acute stroke services across Canada. Prior to joining Dalhousie University, she held academic and leadership positions at the University of Calgary and the University of British Columbia, contributing extensively to clinical research and health technology innovation. Her work bridges engineering, medicine, and health policy, emphasizing interdisciplinary collaboration and patient-centered outcomes. With 107 scientific publications, 8,033 citations, and an h-index of 22, Dr. Kamal has established herself as a recognized scholar in healthcare systems improvement and translational neuroscience. Her scholarly and professional contributions continue to drive evidence-based innovation in stroke systems of care, supporting better clinical outcomes and sustainable health service delivery.

Profiles: Scopus | Google Scholar | Research Gate | Linked In

Featured Publications

Author(s). (2025). Exploring differences in stroke treatment between urban and rural hospitals: A thematic analysis of practices in Canada. Canadian Journal of Neurological Sciences.

Author(s). (2025). Designing a patient outcome clinical assessment tool for modified Rankin Scale: “You feel the same way too”. Informatics.

Author(s). (2025). Predicting ischemic stroke patients to transfer for endovascular thrombectomy using machine learning: A case study. Healthcare (Switzerland).

Author(s). (2025). Incident prescriptions for common cardiovascular medications: Comparison of recent versus pre-2020 medication adherence and discontinuation in three universal health care systems. BMC Cardiovascular Disorders.

Author(s). (2025). Rising out-of-hospital mortality in Canada during 2020–2022: A striking impact observed among young adults. Canadian Journal of Public Health.

Author(s). (2025). Discrete event simulation model of an acute stroke treatment process at a comprehensive stroke center: Determining the ideal improvement strategies for reducing treatment times. Journal of the Neurological Sciences.

Author(s). (2025). Validation of the Passive Surveillance Stroke Severity Score in three Canadian provinces. Canadian Journal of Neurological Sciences.

Author(s). (2025). A stochastic optimization model for designing disaster relief networks with congestion, disruption and distributional ambiguity. Infor.

Author(s). (2025). Improving access and efficiency of acute ischemic stroke treatment across four Canadian provinces: A stepped-wedge trial. Frontiers in Neurology.

Author(s). (2025). The acute stroke system of treatment across Canada: Findings from a national stroke centre survey. Canadian Journal of Neurological Sciences.

Elzbieta Paszynska | Clinical Neuroscience | Best Research Article Award

Published on by Neuroscientists

Prof. Dr. Elzbieta Paszynska | Clinical Neuroscience | Best Research Article Award

Prof. Dr. Elzbieta Paszynska | Poznan University of Medical Sciences | Poland

Professor Elzbieta Paszynska is a distinguished expert in dentistry, serving as Chair of the Department of Integrated Dentistry and Chair of Community Dentistry at Poznan University of Medical Sciences. Her academic focus includes community dentistry, adult comprehensive dental treatment, dental materials, and clinical research in oral health, particularly in patients with eating disorders. She has led numerous significant research projects, including studies on salivary biomarkers, oral health status in eating disorders, and the caries-preventive effects of hydroxyapatite toothpaste in children and adults, collaborating with multiple international institutions. Her research has contributed to over 70 scientific documents with more than 598 citations and an h-index of 13. She has published high-impact works in journals such as Scientific Reports, Frontiers in Public Health, Frontiers in Psychiatry, Nutrients, and the Journal of Dentistry. Her contributions include interdisciplinary projects integrating dentistry, ethics, and public health, and she has coordinated large-scale EU-funded projects and international collaborations. Her work has been recognized with multiple institutional and national awards for scientific excellence, teaching, and professional contributions to dentistry, as well as honors from professional dental associations. She is an active member of national boards and promotes innovation in dental education and research.

Profiles: Scopus | Orcid | Research Gate

Featured Publications

  • Obesity and central accumulation of fat in school-age children with attention-deficit/hyperactivity disorder. (2025). Scientific Reports.

  • Miescher’s Cheilitis as a Diagnostic and Therapeutic Challenge—A Case Report. (2025). Medicina, Kaunas, Lithuania.

  • Prevalence of Toothache in Adults: A Meta-Analysis of Worldwide Studies. (2025).

  • Pain experience and behavior management: efficacy of photobiomodulation as an adjunct to local anesthesia in MIH patients—a randomized split-mouth clinical study. (2025). Frontiers in Neurology.

  • Clinical evidence of caries prevention by hydroxyapatite: An updated systematic review and meta-analysis. (2025).

Hongrui Meng | Neurodegenerative disease | Excellence in Research Award

Published on by Neuroscientists

Prof. Dr. Hongrui Meng | Neurodegenerative disease | Excellence in Research Award

Prof. Dr. Hongrui Meng,  Institute of Neuroscience, Soochow University, China.

Dr. Hongrui Meng is a highly accomplished neuroscientist whose academic path began with a Ph.D. in Behavioural Neuroscience from Hamamatsu University School of Medicine in Japan. He later conducted postdoctoral research in molecular neurobiology and human genetics at Juntendo University, Tokyo. Currently a professor at the Institute of Neuroscience, Soochow University, Dr. Meng leads a research team dedicated to uncovering the molecular and mitochondrial mechanisms underlying Parkinson’s disease and ALS. His work spans high-impact research projects funded by JSPS, NSFC, and other prestigious bodies. In addition to numerous scientific publications, he has contributed to diagnostic innovation through patented miRNA detection methods. His influence extends beyond academia through translational applications such as wearable technologies for Parkinson’s symptom monitoring.

Profile

Orcid

🎓 Early Academic Pursuits

Dr. Hongrui Meng began his distinguished academic journey in the field of neuroscience by earning his Ph.D. in Behavioural Neuroscience from the prestigious Hamamatsu University School of Medicine in Japan. His early education and training laid a strong foundation in experimental neuroscience, with a focus on the behavioral manifestations of neurodegenerative conditions. These formative years not only sharpened his scientific curiosity but also equipped him with the cross-disciplinary expertise to address complex neurological questions.

🧠 Professional Endeavors

Following his doctoral studies, Dr. Meng advanced his specialization through postdoctoral training in molecular neurobiology and human genetics at Juntendo University in Tokyo. There, he immersed himself in high-level research focusing on the genetic underpinnings of neurological disorders. His competence and dedication soon earned him a faculty appointment as an Assistant Professor in the Department of Research for Neurodegenerative Diseases and Dementia. His professional arc reached a significant milestone in 2020 when he was promoted to Full Professor and moved to the Institute of Neuroscience at Soochow University, where he now leads the Laboratory of Molecular Neurology.

🧬 Contributions and Research Focus

Dr. Meng’s scientific contributions center on the molecular mechanisms of Parkinson’s disease and amyotrophic lateral sclerosis (ALS). His research bridges mitochondrial dysfunction, alpha-synuclein aggregation, and neurodegeneration. He has completed pivotal studies supported by the Japan Society for the Promotion of Science and the Takeda Pharmaceutical Foundation, delving into the role of CHCHD2 gene mutations and mitochondrial pathways. His ongoing projects funded by the National Natural Science Foundation of China (NSFC) explore mitochondrial unfolded protein responses (mtUPR), while another innovative project in Suzhou focuses on wearable technology for monitoring Parkinson’s disease symptoms—demonstrating his commitment to translational and patient-centered neuroscience.

🔬 Innovation and Scientific Output

A notable innovator, Dr. Meng has made strides in molecular diagnostic technologies. His work has led to the development of high-throughput RT-qPCR-based methods for detecting primary and precursor miRNAs, contributing to enhanced genetic analysis of neurodegenerative disorders. He holds a patent granted in South Africa and another under process in China, underscoring his role at the intersection of research and technology. Furthermore, his publications in highly regarded journals like Current Issues in Molecular Biology and Cell Communication and Signaling reflect a consistent record of impactful findings that inform both fundamental neuroscience and clinical approaches.

🏅 Accolades and Recognition

Dr. Meng’s ascent in the academic community has been marked by numerous grants, including multiple from the JSPS and NSFC, attesting to the trust placed in his research vision by top funding bodies. While a formal list of awards may be under-documented, his rapid progression from postdoctoral fellow to professor and research team leader in less than a decade speaks volumes about his recognition among peers and institutional leadership. His leadership in multi-disciplinary and international collaborations is an implicit accolade of his scientific reliability and visionary perspective.

🌍 Impact and Influence

Through his groundbreaking work on mitochondrial mechanisms and neurodegeneration, Dr. Meng is helping to reshape current understanding of Parkinson’s disease pathophysiology. His investigations into alpha-synucleinopathy and microglial disruption have provided fresh insights into cellular degeneration and neuroimmune interactions. Beyond academia, his involvement in developing wearable diagnostic tools highlights his drive to impact patient lives directly. As a consultant on neuroprotective treatments such as PD-018/19, he bridges the academic and pharmaceutical worlds to accelerate therapeutic discovery.

🔮 Legacy and Future Contributions

Looking forward, Dr. Meng is poised to be a leading figure in neurogenetic diagnostics and therapeutic innovation. His laboratory at Soochow University serves as an incubator for future discoveries in neurodegenerative disease mechanisms, and his continued work in mitochondrial research promises to inform emerging therapies. With a growing publication record, international patents, and a robust research pipeline, Dr. Meng’s legacy will be one of bridging basic neuroscience with clinical application—paving the way for novel interventions and a better understanding of brain disorders in the molecular era.

Publication

 

  • Title: Dicer Is Involved in Cytotoxicity and Motor Impairment Induced by TBPH Deficiency
    Authors: Xiang Long, Yijie Wang, Hongrui Meng
    Year: 2025

 

  • Title: Transcriptomic analysis of lipid metabolism genes in Alzheimer’s disease: highlighting pathological outcomes and compartmentalized immune status
    Authors: Sun Y., Zhang Y., Jiang M., Long X., Miao Y., Du H., Zhang T., Meng H., Ma X.
    Year: 2024

 

  • Title: CHCHD2 P14L, found in amyotrophic lateral sclerosis, exhibits cytoplasmic mislocalization and alters Ca2+ homeostasis
    Authors: Aya Ikeda, Hongrui Meng, Daisuke Taniguchi, Muneyo Mio, Manabu Funayama, Kenya Nishioka, Mari Yoshida, Yuanzhe Li, Hiroyo Yoshino, Tsuyoshi Inoshita et al.
    Year: 2024

 

  • Title: TDP-43 mutations-induced defects in miRNA biogenesis and cytotoxicity by differentially obstructing Dicer activity in Drosophila and in vitro
    Authors: Xiang Long, Mengni Jiang, Yongzhen Miao, Huanhuan Du, Ting Zhang, Zhuoya Ma, Jiao Li, Chunfeng Liu, Hongrui Meng
    Year: 2024

 

  • Title: A Simple Technique to Assay Locomotor Activity in Drosophila
    Authors: Long X., Du H., Jiang M., Meng H.
    Year: 2023

 

  • Title: Functional MHCI deficiency induces ADHD-like symptoms with increased dopamine D1 receptor expression
    Authors: Meng H.-R., Suenaga T., Edamura M., Nakahara D., Murakami G., Fukuda A., Ishida Y.
    Year: 2021

 

  • Title: Light-driven activation of mitochondrial proton-motive force improves motor behaviors in a Drosophila model of Parkinson’s disease
    Authors: Imai Y., Hattori N., Inoshita T., Shiba-Fukushima K., Meng H., Hara K.Y., Sawamura N.
    Year: 2019

 

  • Title: Mutations in CHCHD2 cause α-synuclein aggregation
    Authors: Ikeda A., Nishioka K., Takanashi M., Li Y., Mori A., Okuzumi A., Izawa N., Ishikawa K.-I., Funayama M., Imai Y. et al.
    Year: 2019

 

  • Title: Parkinson’s disease-associated iPLA2-VIA/PLA2G6 regulates neuronal functions and α-synuclein stability through membrane remodeling
    Authors: Mori A., Hatano T., Koinuma T., Kubo S.-I., Spratt S., Yamashita C., Okuzumi A., Imai Y., Hattori N., Inoshita T. et al.
    Year: 2019

 

  • Title: Twin CHCH proteins, CHCHD2, and CHCHD10: Key molecules of Parkinson’s disease, amyotrophic lateral sclerosis, and frontotemporal dementia
    Authors: Imai Y., Hattori N., Meng H., Shiba-Fukushima K.
    Year: 2019

 

🧾 Conclusion

Dr. Hongrui Meng’s career reflects a dynamic blend of academic excellence, molecular research innovation, and translational neuroscience. His scientific endeavors have not only enriched the understanding of neurodegenerative diseases but have also paved the way for novel diagnostic and therapeutic strategies. With a growing portfolio of impactful research, patents, and leadership in neurobiology, Dr. Meng stands out as a driving force in the global fight against neurological disorders. His work promises continued contributions to neuroscience with lasting influence on both scientific knowledge and patient care.

 

Nai-Bing Gu | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Dr. Nai-Bing Gu | Clinical Neuroscience | Best Researcher Award

Dr. Gu Naibing is a distinguished Chief Physician in the Department of Neurology at Xi’an Central Hospital, specializing in neuroimmunology. He has made significant contributions to the understanding of neurological diseases, particularly those related to autoimmune and inflammatory conditions of the nervous system. As a Master’s degree supervisor and an active member of several professional committees, Dr. Gu has established himself as a leader in the fields of neurology and neuroimmunology. His research, clinical expertise, and involvement in medical organizations have earned him recognition and influence in the medical community. His work continues to have a lasting impact on both the treatment of neurological diseases and the education of future healthcare professionals.

Profile

Scopus

 

👨‍⚕️ Early Academic Pursuits

Dr. Gu Naibing embarked on his academic journey with a keen interest in neurology and medicine. After completing his medical degree, he pursued further studies in the specialized field of neurology, which led to the completion of his Master’s degree. Throughout his academic tenure, Dr. Gu consistently demonstrated a strong dedication to advancing his understanding of complex neurological conditions. His early academic endeavors set the foundation for a career focused on improving patient outcomes and advancing scientific knowledge in neuroimmunology.

💼 Professional Endeavors

Dr. Gu Naibing has established himself as a prominent figure in the field of neurology. As a Chief Physician in the Department of Neurology at Xi’an Central Hospital, he plays a vital role in diagnosing and treating a wide range of neurological disorders. Additionally, he serves as a Master’s degree supervisor, contributing to the training and development of the next generation of medical professionals. His professional network includes multiple roles in prestigious committees, such as the Neuroimmunology Professional Committee of the Shaanxi Provincial International Medical Exchange Promotion Association and the Neurology Branch of the Xi’an Medical Association.

🔬 Contributions and Research Focus

Dr. Gu’s research primarily focuses on neuroimmunology, the intersection of the immune system and neurological diseases. His work has advanced understanding in this field, particularly with regard to the mechanisms underlying autoimmune disorders affecting the nervous system. By contributing to a deeper understanding of brain diseases, Dr. Gu’s research has had significant implications for the development of more effective treatments for patients suffering from conditions such as multiple sclerosis, encephalitis, and other neuroinflammatory disorders. His focus on integrating immunological and neurological disciplines has been pivotal in pushing the boundaries of clinical research.

🏆 Accolades and Recognition

Throughout his career, Dr. Gu Naibing has earned several accolades and recognition for his outstanding contributions to the medical field. His involvement in various professional committees highlights his leadership and influence in the realm of neurology and neuroimmunology. As a standing committee member of the Neuroimmunology Group and the Neurology Professional Committee of the Shaanxi Health Care Association, Dr. Gu’s expertise and leadership are regularly sought after. His recognition extends beyond clinical practice, as he is frequently invited to contribute to national and international discussions on neurological care and research.

🌍 Impact and Influence

Dr. Gu Naibing’s influence extends beyond his clinical and research activities. Through his active involvement in professional organizations, he has had a profound impact on the development of neurology and neuroimmunology practices in China. His leadership in committees, particularly within the Shaanxi Medical Communication Association, has helped bridge gaps between medical professionals, facilitating the exchange of ideas and research findings. His dedication to fostering collaboration among medical communities has contributed to the enhancement of healthcare practices and the overall improvement of patient care.

🧠 Legacy and Future Contributions

As Dr. Gu Naibing continues his work, his legacy in the fields of neurology and neuroimmunology will undoubtedly inspire future generations of healthcare professionals. His commitment to advancing both clinical and research practices ensures that his contributions will have a lasting impact on the treatment of neurological diseases. Looking ahead, Dr. Gu is poised to continue making significant strides in neuroimmunology, with ongoing research and collaborations aimed at developing new therapeutic approaches. His future contributions promise to further shape the landscape of neurological healthcare, enhancing the lives of patients around the world.

🌟 Final Thoughts

Dr. Gu Naibing’s career has been defined by his passion for neurology, his commitment to advancing research, and his tireless efforts to improve patient outcomes. As a clinician, educator, and researcher, he has earned the respect and admiration of his peers, contributing significantly to the advancement of medical knowledge and patient care. With his continued dedication to the field, Dr. Gu’s legacy is sure to endure, influencing both the scientific community and the generations of healthcare professionals who follow in his footsteps.

Publication

  • Title: Effect of BMSCs overexpressing intelectin-1 on angiogenesis in rats with cerebral infarction
    Authors: B. Zhu, K. Guo, L. Zha, L. Chang, N. Gu
    Year: 2025

 

  • Title: Salivary duct carcinoma presenting with unilateral multiple cranial nerve lesions and concurrent intracranial metastasis: A case report
    Authors: B. Zhu, Q. Zhang, K. Guo, Y. Yang, X. Jia
    Year: 2025

 

Conclusion

Dr. Gu Naibing’s career is a testament to his dedication to advancing the field of neurology and neuroimmunology. His groundbreaking research, leadership in medical committees, and commitment to education have shaped the future of neurological care in China. With his continued focus on improving patient care and expanding scientific knowledge, Dr. Gu is poised to make lasting contributions that will positively impact both the medical field and the lives of countless patients. His legacy will inspire future generations of researchers and clinicians in the realm of neurology.

 

Camilla Bellone | Translational Neuroscience | Best Researcher Award

Published on by Neuroscientists

Assoc. Prof. Dr. Camilla Bellone | Translational Neuroscience | Best Researcher Award

Assoc. Prof. Dr. Camilla Bellone,  University of Geneva, Switzerland.

Dr. Camilla Bellone is a renowned neuroscientist whose academic and research career has been marked by excellence, innovation, and impact. From her foundational training in Italy to her leadership role in Geneva, she has made pioneering contributions to understanding the neural underpinnings of social behavior. Her work bridges basic science and clinical relevance, and she has played a vital role in training, mentorship, and international collaboration within the neuroscience community.

Profile

Google Scholar

 

🎓 Early Academic Pursuits

Dr. Camilla Bellone began her academic journey with a Master’s degree in Pharmacy from the University of Milano in 2000. With a strong foundation in pharmacology and medical chemistry, she pursued her Ph.D. in “Pharmacology, Toxicology, and Medical Chemotherapy” at the same institution, completing it in 2006. Her early education shaped a robust scientific mindset, preparing her for a career at the intersection of neuroscience and pharmacology. These formative years set the tone for her later work on the molecular mechanisms that govern complex behaviors in both healthy and diseased states.

🧪 Professional Endeavors

After her doctoral studies, Dr. Bellone enhanced her research acumen through a postdoctoral fellowship at the University of California, San Francisco (UCSF), gaining international exposure. She later returned to Switzerland, where she served as a scientist under the Ambizione Fellowship at the University of Geneva. Her academic path took a significant leap when she became an Assistant Professor at the University of Lausanne in 2014, followed by a transition to the University of Geneva in 2016. In 2020, she was promoted to Associate Professor in the Department of Basic Neuroscience, where she continues to lead cutting-edge investigations and mentor future neuroscientists.

🧠 Contributions and Research Focus

At the core of Dr. Bellone’s research lies a deep interest in the neurobiological basis of social behavior, with a particular focus on how these processes are disrupted in neuropsychiatric disorders. Her lab explores the synaptic and circuit-level mechanisms that underpin social cognition, often using advanced molecular and behavioral techniques. Her work has provided critical insights into how alterations in neural plasticity and connectivity contribute to diseases such as schizophrenia and autism spectrum disorders. With over 40 peer-reviewed publications in high-impact journals like Nature Neuroscience and Neuron, Dr. Bellone’s research continues to advance the field of behavioral neuroscience.

🏆 Accolades and Recognition

Dr. Bellone’s scientific excellence has been recognized through several prestigious honors. In 2023, she received the EBBS Mid-Career Award and the Leenaards Scientific Prize for her collaborative project on cerebellar stimulation in schizophrenia. Earlier, she was elected to the distinguished FENS-KAVLI Network of Excellence in 2015, highlighting her position among Europe’s most promising neuroscientists. In 2014, she was honored with the Fondation du Prix Pfizer de la Recherche, marking an early milestone in her independent research career.

🌍 Impact and Influence

Beyond her lab, Dr. Bellone has made meaningful contributions to the academic and scientific community. She has delivered over 20 invited lectures at international conferences and institutions, sharing her discoveries with a global audience. As a dedicated mentor, she has guided eight master’s students and seven PhD candidates, nurturing the next generation of neuroscientists. Her commitment extends to active service on academic committees, grant review panels, and editorial boards, reflecting her role as a respected leader in the field.

👩‍🔬 Balancing Science and Life

A champion of work-life integration, Dr. Bellone has managed to thrive professionally while embracing motherhood. She took two career breaks following the birth of her three children, exemplifying resilience and balance in a demanding academic landscape. Her story is an inspiration to young scientists, especially women, striving to build careers in STEM while honoring personal life choices.

🔬 Legacy and Future Contributions

Looking ahead, Dr. Bellone’s work holds promise for transforming our understanding of social dysfunction in mental illness. Her innovative approaches—blending circuit neuroscience, pharmacology, and behavior—position her as a leading voice in the neurobiology of social behavior. With continued support from initiatives like the ERC Consolidator Grant, her research will likely pave the way for novel therapeutic interventions, leaving a lasting legacy in neuroscience and psychiatry.

Publication

  • Title: NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease
    Author: P Paoletti, C Bellone, Q Zhou
    Year: 2013

 

  • Title: Cocaine triggered AMPA receptor redistribution is reversed in vivo by mGluR-dependent long-term depression
    Author: C Bellone, C Lüscher
    Year: 2006

 

  • Title: Rapid bidirectional switching of synaptic NMDA receptors
    Author: C Bellone, RA Nicoll
    Year: 2007

 

  • Title: Cocaine inverts rules for synaptic plasticity of glutamate transmission in the ventral tegmental area
    Author: M Mameli, C Bellone, MTC Brown, C Lüscher
    Year: 2011

 

  • Title: In vivo reprogramming of circuit connectivity in postmitotic neocortical neurons
    Author: A De la Rossa, C Bellone, B Golding, I Vitali, J Moss, N Toni, C Lüscher, …
    Year: 2013

 

  • Title: Mechanisms of synaptic depression triggered by metabotropic glutamate receptors
    Author: C Bellone, C Lüscher, M Mameli
    Year: 2008

 

  • Title: Effects of streptozotocin‐diabetes on the hippocampal NMDA receptor complex in rats
    Author: F Gardoni, A Kamal, C Bellone, GJ Biessels, GMJ Ramakers, F Cattabeni, …
    Year: 2002

 

  • Title: Neurons under T cell attack coordinate phagocyte-mediated synaptic stripping
    Author: G Di Liberto, S Pantelyushin, M Kreutzfeldt, N Page, S Musardo, R Coras, …
    Year: 2018

 

  • Title: mGluRs induce a long‐term depression in the ventral tegmental area that involves a switch of the subunit composition of AMPA receptors
    Author: C Bellone, C Lüscher
    Year: 2005

 

  • Title: SHANK3 controls maturation of social reward circuits in the VTA
    Author: S Bariselli, S Tzanoulinou, C Glangetas, C Prévost-Solié, L Pucci, …
    Year: 2016

 

✅ Conclusion

Dr. Bellone’s journey reflects a remarkable blend of scientific curiosity, academic leadership, and personal resilience. As she continues to explore the brain’s most intricate social circuits, her influence will undoubtedly expand across neuroscience, psychiatry, and therapeutic innovation. Her career serves as both a roadmap and an inspiration for emerging scientists navigating the evolving landscape of brain research.